Are patients with HHV-8 associated Castleman disease successfully treated with rituximab at risk of subsequently developing HHV-8 negative (idiopathic) Castleman disease? [PDF]
European Journal of Case Reports in Internal Medicine, 2023 Introduction: Multicentric Castleman disease (MCD) is a lymphoproliferative disorder characterized by lymph node histopathology and systemic symptoms.
Gavin Ha +4 more
doaj +2 more sources
Epidemiology and Genetic Variability of HHV-8/KSHV among Rural Populations and Kaposi’s Sarcoma Patients in Gabon, Central Africa. Review of the Geographical Distribution of HHV-8 K1 Genotypes in Africa [PDF]
Viruses, 2021 Human herpesvirus 8 (HHV-8) is the etiological agent of all forms of Kaposi’s sarcoma (KS). K1 gene studies have identified five major molecular genotypes with geographical clustering.
Antony Idam Mamimandjiami +8 more
doaj +2 more sources
HHV-8-Associated Lymphoproliferative Disorders and Pathogenesis in an HIV-Positive Patient [PDF]
Case Reports in Hematology, 2019 Human herpesvirus 8 (HHV-8), also known as Kaposi’s sarcoma-associated herpesvirus, is a DNA oncovirus known for its role in the development of Kaposi’s sarcoma (KS) and several lymphoproliferative disorders (LPDs). HHV-8 promotes lymphoproliferation via
Carlo Guerrero +2 more
doaj +2 more sources
HHV-8 and EBV Positive Lymphoproliferative Disease: A Challenging Case [PDF]
Türk Patoloji Dergisi, 2022 Human herpes virus-8 (HHV-8) is linked to four lymphoproliferative diseases: primary effusion lymphoma, HHV-8 positive multicentric Castleman disease (MCD), HHV-8 positive diffuse large B cell lymphoma and HHV-8 positive germinotropic lymphoproliferative
Göksenil BÜLBÜL +3 more
doaj +2 more sources
Angiosarcoma in HIV-negative patients is not associated with HHV-8 [PDF]
Anais Brasileiros de Dermatologia, 2016 : BACKGROUND: Angiosarcoma is an aggressive, malignant neoplasm of vascular or lymphatic origin. Herpes virus 8 (HHV-8) is a member of the herpes family with a tropism for endothelial cells and it has been proven to induce vascular neoplasms, such as ...
João Avancini +8 more
doaj +3 more sources
SARS-CoV-2-Specific T Cell Immunity in HIV-Associated Kaposi Sarcoma Patients in Zambia
Journal of Immunology Research, 2022 Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) virus is the cause of coronavirus disease 2019 (COVID-19). It has caused millions of infections and deaths globally over a 2-year period.
Owen Ngalamika +7 more
doaj +1 more source
Non-detection of human herpesvirus 8 (HHV-8) DNA in HHV-8-seropositive blood donors from three Brazilian regions. [PDF]
PLoS ONE, 2011 Human herpesvirus 8 (HHV-8), also known as Kaposi's sarcoma-associated herpesvirus (KSHV), is the etiologic agent of all forms of Kaposi's sarcoma, primary effusion lymphoma and the plasmablastic cell variant of multicentric Castleman disease. In endemic
José Eduardo Levi +6 more
doaj +1 more source
Virology Journal, 2021 Background Regard to this fact that the main transmission route of HPV and HHV-8 is via sexual activity, it is reasonable to speculate that coinfection of HPV and HHV-8 may have been played an important role in the development of cervical cancer. The aim
Sara Chavoshpour-Mamaghani +4 more
doaj +1 more source
Scientific Reports, 2021 Human herpesvirus 8 (HHV8) is endemic in Africa, although studies of this infection are rare in Congo. We evaluated seroprevalence and HHV-8 diversity among people living with HIV.
Gervillien Arnold Malonga +9 more
doaj +1 more source
Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda. [PDF]
PLoS ONE, 2009 Kaposi sarcoma (KS) is the leading cause of cancer in Uganda and occurs in people with and without HIV. Human herpesvirus-8 (HHV-8) replication is important both in transmission of HHV-8 and progression to KS.
Christine Johnston +14 more
doaj +1 more source